Why NIH needs evolution expertise–The amyloid beta case study

Sharon Begley has written a lovely article on Tanzi and Moir’s research on the antimicrobial properties of amyloid beta and the outrageous difficulty they have had getting NIH to fund their work. They noted that study after study has found no benefit from...

How EvMed Misled Me—The ASA saga

The history of medicine is replete with examples of the disasters that result when clinical practice is guided by theory alone. For instance, in the early 20th century sudden infant death was attributed to suffocation caused by an enlarged thymus.1 Thousands of...
Submissions invited for a special issue of JERPH

Submissions invited for a special issue of JERPH

Guest editors Nicole Bender and Kaspar Straub invite submissions for a special issue of Environmental Research and Public Health on  “Evolutionary Medicine: Environmental Health Issues”  The deadline is September, 2019. Full details here. Buy...

Did natural selection build in adaptive therapy for cancer?

A new article proposes that adaptive therapy for cancer has been there all along as one of the body’s ways of preventing cancer.  Thomas, F., Donnadieu, E., Charriere, G. M., Jacqueline, C., Tasiemski, A., Pujol, P., … Ujvari, B. (2018). Is adaptive therapy...